Autopsy report · NCT03875560

IC14 in Adult Patients With Dengue Fever

“withdrawn, no enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Implicit Bioscience

Sponsor type

Industry

Conditions

Dengue Fever

Interventions

IC14; Placebo

Participants

0

Trials that died the same way

• Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
  “Withdrawn: study halted prematurely, prior to enrollment of first participant” (80% match in meaning)
• AIM4 AI and Mechanistic Modeling in Molecular Medicine
  “Withdrawn No Participants Enrolled” (78% match in meaning)
• RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain
  “Funding withdrawn - slow enrollment” (78% match in meaning)
• Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome
  “Study withdrawn prior to enrollment due to sponsor decision” (77% match in meaning)
• Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
  “Study was withdrawn due to lack of patient enrollment.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.